Whole Genome Sequencing in Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

August 2, 2022

Primary Completion Date

August 2, 2025

Study Completion Date

December 31, 2030

Conditions
Breast Cancer
Interventions
OTHER

no intervention needed

no intervention needed

Trial Locations (1)

Unknown

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Inocras Korea Inc.

INDUSTRY